Moberg Pharma AB sell BiotechBee
Start price
13.05.24
/
70%
€2.37
Target price
31.05.26
€1.50
Performance (%)
-0.84%
End price
14.05.24
€2.35
Summary
This prediction ended on 14.05.24 with a price of €2.35. From the start of the prediction for Moberg Pharma AB the price only changed by -0.84%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moberg Pharma AB | -4.570% | -4.570% | 9.557% |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
According to BiotechBee what are the pros and cons of Moberg Pharma AB for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year